Loading…
Employees: 1,864
Size Lee & Man Chemical (0746.HK) is a Hong Kong Materials company (Chemicals: Specialty) with a market value of $465M, the 776th largest of 891 Hong Kong companies the cockpit tracks. Shares closed at HK$4.42 on 6 Nov 2026.
Performance Over six months the shares fell 9.2%, against -20.0% for the median peer and -13.4% for the Hong Kong market (cap-weighted) — 8th highest of 21 in its peer set.
Growth Revenue grew 2.5% over the last twelve months (peer median +11.5%); the operating margin is 18.2% (peer median 1.4%).
Valuation It trades at 6.1× forward earnings against a peer median of 21.5× (3rd cheapest of 9).
Price implies For today's price to make sense, revenue must grow about -8% a year for seven years (Req g). Recent delivered growth is +4%, so the hurdle is -12 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 0.8 points above its cost of capital (7.1% WACC).
Next results Next results expected around 11 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | HK$3.99B | HK$3.75B | HK$3.95B | HK$4.05B | HK$5.87B |
| Revenue growth | — | -5% | -2% | -31% | — |
| Gross profit | HK$1.37B | HK$1.29B | HK$1.16B | HK$1.06B | HK$2.12B |
| EBITDA | HK$826M | HK$760M | HK$630M | HK$538M | HK$1.47B |
| Net income | HK$581M | HK$558M | HK$482M | HK$401M | HK$1.16B |
| Free cash flow | HK$152M | HK$479M | HK$265M | HK$108M | HK$956M |
| Capital expenditure | HK$595M | HK$512M | HK$774M | HK$614M | HK$611M |
| Total debt | n/a | HK$787M | HK$653M | HK$679M | HK$746M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 0746.HK | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +1.7% | -11.8% | 2nd highest of 21 |
| 6-month return | -9.2% | -20.0% | 8th highest of 21 |
| Distance from 52-week high | -31.2% | -40.3% | 7th highest of 21 |
| Revenue growth (TTM) | +2.5% | +11.5% | 6th lowest of 21 |
| Operating margin | 18.2% | 1.4% | highest of 21 |
| Forward P/E | 6.1× | 21.5× | 3rd cheapest of 9 |
| Growth the price implies (Req g, 7 yrs) | -8.5% | 15.5% | 2nd least demanding of 14 |
| Growth delivered (Del g) | +3.9% | +7.2% | 6th lowest of 14 |
| Hurdle (Req g minus delivered) | -12.4 pp | -5.2 pp | 3rd least demanding of 14 |
| ROIC minus cost of capital | +0.8 pp | -6.0 pp | 4th highest of 21 |
| EV / EBITDA | 5.4× | 12.8× | 3rd cheapest of 8 |
| Net debt / EBITDA | 1.0× | 1.8× | 5th least indebted of 10 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Lee & Man Chemical 0746.HK | Hong Kong | $465M | -9% | +3% | 18% | 6.1× | -8.5% | +3.9% |
| Dymatic Chemicals 002054.SZ | China | $465M | -25% | +21% | 8% | n/a | -0.8% | +12.9% |
| Kente Catalysts 603120.SS | China | $465M | +6% | +9% | 12% | n/a | 18.3% | -8.9% |
| Nantong Jiangtian Chemical 300927.SZ | China | $463M | -29% | +51% | 5% | n/a | 18.0% | +29.0% |
| JSP 7942.T | Japan | $462M | +29% | +14% | 8% | 9.9× | -4.0% | +7.2% |
| FuJian Nox Bellcow 300132.SZ | China | $459M | -37% | +18% | 7% | 17.9× | 3.1% | -10.5% |
| Ho Tung Chemical 1714.TW | Taiwan | $459M | +67% | +36% | 10% | n/a | -17.3% | -1.5% |
| Braskem S.A. Sponsored ADR Pfd BAK | United States | $457M | -70% | -1% | 1% | 1.0× | n/a | n/a |
| Shaanxi Xinghua Chemistry 002109.SZ | China | $473M | -39% | +20% | -1% | n/a | 2.0% | +13.0% |
| Valhi VHI | United States | $456M | +11% | +3% | 1% | 4.6× | 32.2% | +2.3% |
| Zhejiang Hisun Biomaterials 688203.SS | China | $473M | +16% | +47% | 4% | 56.0× | 16.5% | +26.6% |
| Advansix ASIX | United States | $454M | -17% | +8% | -1% | 90.9× | 55.3% | +5.6% |
| Gujarat Alkalies & Chemicals GUJALKALI.NS | India | $476M | -23% | +7% | 2% | n/a | 39.8% | +12.5% |
| Shanghai Huide Science & Technology 603192.SS | China | $476M | -15% | +2% | 3% | n/a | 15.5% | +10.5% |
| Changhua Chemical Technology 301518.SZ | China | $452M | -45% | +17% | -2% | n/a | n/a | n/a |
| Tian Jin Bohai Chemical 600800.SS | China | $479M | -37% | -24% | -20% | n/a | n/a | n/a |
| Soulbrain 036830.KS | South Korea | $480M | -55% | +16% | -3% | n/a | n/a | n/a |
| Laxmi Organic Industries LXCHEM.NS | India | $480M | 0% | +5% | 6% | 25.1× | n/a | n/a |
| Jiangxi Chenguang New Materials 605399.SS | China | $482M | -30% | +15% | -9% | 129.1× | n/a | n/a |
| Renxin New Material 301395.SZ | China | $445M | -10% | +1% | -6% | n/a | n/a | n/a |
| UPC Technology 1313.TW | Taiwan | $445M | +4% | -1% | -23% | n/a | -2.6% | +2.5% |